Common Contracts
2 similar Placement Agent Agreement contracts by American Bio Medica Corp
PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • April 7th, 2014 • American Bio Medica Corp • Pharmaceutical preparations • New York
This letter confirms our agreement (the “Agreement”) that American Bio Medica Corporation, a New York corporation (“ABMC “ or the “Company”) has engaged Cantone Research, Inc. (“CRI” or the “Placement Agent”) to act as the Company’s exclusive Placement Agent in connection with the proposed solicitation (the “Offering”) of current holders of ABMC 15% Subordinated convertible Debentures Due August 1, 2013 (the “Existing Debt”) to exchange the Existing Debt for two series of new convertible notes (the “New Notes”) described below. The New Notes consist of two series of new convertible notes, as follows: up to $400,000 of 15% notes due August 1, 2014 (the “Series 2013A Notes”), with a warrant attached to purchase one share of ABMC common stock for each $1.00 in principal amount of Existing Debt exchanged for the Series 2013A Notes (the “Warrants”); and up to $400,000 of 15% notes due February 1, 2014 (the “Series 2013B Notes”). Each series of New Notes will pay 15% simple interest quarterl
PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • July 31st, 2012 • American Bio Medica Corp • Pharmaceutical preparations • New York
This letter confirms our agreement that American Bio Medica Corporation, a New York corporation (“ABMC ” or the "Company”) has engaged Cantone Research, Inc. (“CRI” or the “Placement Agent”) to act as the Company’s exclusive Placement Agent in connection with the proposed amendment (the “Offering”) of the Company’s existing $750,000 10% Subordinated Convertible Debentures due August 1, 2012, Series A to 15% Subordinated Convertible Debentures due August 1, 2013, Series A (the “Debentures”, and, together with the Company’s common stock into which the Debentures are convertible, the “Securities”), pursuant to the Company’s private offering memorandum dated July 20, 2012 (the “Memorandum”). The terms of the Offering and the proposed uses of the gross proceeds of such Offering are summarized in Exhibit A to this Placement Agent Agreement (the “Agreement”). The Offering will be made solely to “accredited investors” (the “Accredited Investors”), as such term is defined in Rule 501(a) of Regu
